{"disease":{"id":"metastasis-lung","name":"metastasis lung"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04281784","title":"Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2512,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT05933876","title":"The Impact of Radiotherapy on Oligometastatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT06718972","title":"A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT03721952","title":"Facilitating Communication Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":977,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT06563388","title":"Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT04283994","title":"Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":756,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT04886804","title":"Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":608,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT03797391","title":"A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":186,"lead_sponsor_name":"Shanghai EpimAb Biotherapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT01724801","title":"Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"Guangdong Association of Clinical Trials","has_results":false},{"nct_id":"NCT02376699","title":"Safety Study of SEA-CD40 in Cancer Patients","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":159,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT06362369","title":"A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"7 Hills Pharma, LLC","has_results":false},{"nct_id":"NCT07173348","title":"Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":82,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT04148898","title":"Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT03681873","title":"Validation of Low Dose CT for Diagnosis of Lung Nodules","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05310539","title":"Early Recovery After \"Wedge Resection\" Surgery to Remove Lung Mestastasis Secondary to Bone Cancer.","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT04066699","title":"Percutaneous Localization: Open-label Registry of Thoracic Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Veran Medical Technologies","has_results":false},{"nct_id":"NCT06399926","title":"Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir","phase":"","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03166631","title":"A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":62,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT02013297","title":"Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT02014116","title":"A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":51,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT00219297","title":"Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03415126","title":"A Study of ASN007 in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Asana BioSciences","has_results":false},{"nct_id":"NCT04486287","title":"Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Tianjin Medical University Second Hospital","has_results":false},{"nct_id":"NCT05414123","title":"A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide","phase":"","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Biocept, Inc.","has_results":false},{"nct_id":"NCT07398599","title":"Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT04833205","title":"Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Hui Bu","has_results":false},{"nct_id":"NCT04788147","title":"Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"RefleXion Medical","has_results":true},{"nct_id":"NCT04425681","title":"Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT03092934","title":"A Study of AK-01 (LY3295668) in Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT05257967","title":"CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT06872489","title":"Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Second Life Therapeutics","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}